보포스트 그룹
평가액
$12.53B
보유 종목
58
상위 10 비중
65.0%
보유 종목
58종목| 종목 | 보유수량 | 평가액 ▼ | 신고가 | 현재가 | ±신고 | 52주 | 비중 |
|---|---|---|---|---|---|---|---|
| INTEL CORP | 23,305,334 | $1.492B | $64.00 | $59.66 | -6.8% | $33.62 – $140.94 | 11.9% |
| LIBERTY GLOBAL PLC | 54,555,407 | $1.393B | $25.54 | - | - | - | 11.1% |
| EBAY INC | 18,324,423 | $1.122B | $61.24 | $120.92 | +97.5% | $79.41 – $125.15 | 9.0% |
| QORVO INC | 5,224,466 | $954.5M | $182.70 | - | - | - | 7.6% |
| VIASAT INC | 16,288,959 | $783M | $48.07 | $67.72 | +40.9% | $30.35 – $89.81 | 6.3% |
| ALPHABET INC | 290,930 | $601.8M | $2,068.63 | $292.52 | -85.9% | $273.14 – $399.04 | 4.8% |
| <![CDATA[WILLIS TOWERS WATSON PLC LTD]]> | 2,500,000 | $572.2M | $228.88 | $335.34 | +46.5% | $242.12 – $350.75 | 4.6% |
| MICRON TECHNOLOGY INC | 5,423,416 | $478.4M | $88.21 | $778.31 | +782.3% | $201.37 – $1,213.56 | 3.8% |
| META PLATFORMS INC | 1,297,000 | $382M | $294.53 | $641.69 | +117.9% | $525.72 – $777.59 | 3.0% |
| PG&E CORP | 30,657,601 | $359M | $11.71 | $13.25 | +13.2% | $11.95 – $19.11 | 2.9% |
| PERSHING SQUARE TONTINE HLDG | 12,707,924 | $305.1M | $24.01 | - | - | - | 2.4% |
| TRANSLATE BIO INC | 18,044,239 | $295.8M | $16.39 | - | - | - | 2.4% |
| INTERNATIONAL FLAVORS&FRAGRA | 2,100,000 | $293.2M | $139.61 | $81.16 | -41.9% | $63.25 – $94.63 | 2.3% |
| NEXSTAR MEDIA GROUP INC | 2,085,000 | $292.8M | $140.43 | $207.94 | +48.1% | $154.70 – $253.64 | 2.3% |
| LIBERTY MEDIA CORP DELAWARE | 6,484,867 | $286M | $44.11 | - | - | - | 2.3% |
| Fox Corp. | 7,610,818 | $274.8M | $36.11 | $68.42 | +89.5% | $48.79 – $76.11 | 2.2% |
| SS&C TECH HLDGS | 3,806,892 | $266M | $69.87 | $79.50 | +13.8% | $62.05 – $89.62 | 2.1% |
| Fox Corp. | 5,680,307 | $198.4M | $34.93 | $61.11 | +75.0% | $44.39 – $67.76 | 1.6% |
| LIBERTY GLOBAL PLC | 7,657,205 | $196.5M | $25.66 | - | - | - | 1.6% |
| THERAVANCE BIOPHARMA INC | 8,735,168 | $178.3M | $20.41 | - | - | - | 1.4% |
| HEALTHPEAK PROPERTIES INC | 4,966,911 | $157.7M | $31.74 | $19.98 | -37.1% | $15.78 – $22.82 | 1.3% |
| COLONY CAP INC NEW | 24,212,959 | $156.9M | $6.48 | - | - | - | 1.3% |
| LIBERTY MEDIA CORP DELAWARE | 3,500,000 | $154.3M | $44.08 | - | - | - | 1.2% |
| VERITIV CORP | 3,564,439 | $151.6M | $42.54 | - | - | - | 1.2% |
| ADVANTAGE SOLUTIONS INC | 12,500,000 | $143.6M | $11.49 | - | - | - | 1.1% |
| VERINT SYS INC | 3,039,798 | $138.3M | $45.49 | - | - | - | 1.1% |
| FIDELITY NATL FINL INC | 3,036,935 | $123.5M | $40.66 | $43.41 | +6.8% | $38.65 – $57.61 | 1.0% |
| ATARA BIOTHERAPEUTICS INC | 8,477,488 | $121.7M | $14.36 | - | - | - | 1.0% |
| NUVATION BIO INC | 8,623,021 | $82.38M | $9.55 | $3.99 | -58.2% | $3.99 – $9.54 | 0.7% |
| CULLINAN ONCOLOGY INC | 1,835,560 | $71.7M | $39.06 | $10.28 | -73.7% | $8.45 – $22.95 | 0.6% |
| REINVENT TECHNOLOGY PARTNERS | 6,000,000 | $60.24M | $10.04 | - | - | - | 0.5% |
| AJAX I | 5,000,000 | $51.3M | $10.26 | - | - | - | 0.4% |
| THOMA BRAVO ADVANTAGE | 4,000,000 | $41.8M | $10.45 | - | - | - | 0.3% |
| AVANTI ACQUISITION CORP | 4,000,000 | $39.08M | $9.77 | - | - | - | 0.3% |
| HORIZON ACQUISITION CORPORAT | 3,499,998 | $35.7M | $10.20 | - | - | - | 0.3% |
| REINVENT TECHNOLOGY PARTNERS | 3,500,000 | $35.53M | $10.15 | - | - | - | 0.3% |
| LIBERTY MEDIA ACQUISITION CO | 3,200,000 | $32.35M | $10.11 | - | - | - | 0.3% |
| BROADSTONE ACQUISITION CORP | 2,970,000 | $29.08M | $9.79 | - | - | - | 0.2% |
| TRILOGY METALS INC NEW | 12,182,568 | $26.07M | $2.14 | $1.94 | -9.3% | $1.94 – $6.89 | 0.2% |
| ALTIMETER GROWTH CORP 2 | 2,500,000 | $25.95M | $10.38 | - | - | - | 0.2% |
| INVESTINDUSTRIAL ACQUISITION | 2,100,000 | $20.48M | $9.75 | - | - | - | 0.2% |
| DRAGONEER GROWTH OPT CORP II | 2,000,000 | $20.22M | $10.11 | - | - | - | 0.2% |
| FINCH THERAPEUTICS GROUP INC | 1,208,159 | $18.87M | $15.62 | - | - | - | 0.2% |
| PERSHING SQUARE TONTINE HLDG | 1,944,444 | $15.85M | $8.15 | - | - | - | 0.1% |
| DRAGONEER GROWTH OPPTY CORP | 1,000,000 | $10.28M | $10.28 | - | - | - | 0.1% |
| SVF INVESTMENT CORP | 1,000,000 | $10.21M | $10.21 | - | - | - | 0.1% |
| REINVENT TECHNOLOGY PARTNERS | 1,000,000 | $10.01M | $10.01 | - | - | - | 0.1% |
| VESPER HEALTHCARE ACQSTN COR | 1,320,000 | $2.746M | $2.08 | - | - | - | 0.0% |
| HORIZON ACQUISITION CORPORAT | 1,166,666 | $2.392M | $2.05 | - | - | - | 0.0% |
| REDBALL ACQUISITION CORP | 1,650,000 | $2.244M | $1.36 | - | - | - | 0.0% |
| AJAX I | 1,250,000 | $2.113M | $1.69 | - | - | - | 0.0% |
| AVANTI ACQUISITION CORP | 2,000,000 | $2.1M | $1.05 | - | - | - | 0.0% |
| LIBERTY MEDIA ACQUISITION CO | 640,000 | $1.933M | $3.02 | - | - | - | 0.0% |
| REINVENT TECHNOLOGY PARTNERS | 875,000 | $1.768M | $2.02 | - | - | - | 0.0% |
| BROADSTONE ACQUISITION CORP | 1,485,000 | $1.025M | $0.69 | - | - | - | 0.0% |
| INVESTINDUSTRIAL ACQUISITION | 700,000 | $574K | $0.82 | - | - | - | 0.0% |
| SVF INVESTMENT CORP | 200,000 | $414K | $2.07 | - | - | - | 0.0% |
| REINVENT TECHNOLOGY PARTNERS | 200,000 | $316K | $1.58 | - | - | - | 0.0% |
59개 신고 항목을 58개 CUSIP으로 합산했습니다. 위임 운용사별로 나뉜 항목은 합산합니다.
13F는 롱 포지션만(롱옵션 포함, 숏·현금 제외)이며 분기말 기준입니다.
그 외 신고 항목
1건| 종목 | 종류 | 수량·원금 | 평가액 |
|---|---|---|---|
| THERAVANCE BIOPHARMA INC | 원금 표시(채권·노트) | 30,000,000 | $30.58M |
채권·노트(원금 표시)·선호주·예탁증권·값 없는 항목·옵션(콜·풋)은 참고로 싣되 평가액·종목수에는 세지 않습니다 — 주식수 기준·값 0 초과·옵션 제외·선호주 제외(Dataroma 방식). 옵션은 계약 수가 아니라 기초 주식수와 그 평가액으로 적습니다.